Howard Dean — for hire
Salon has an article today with this title: The seduction of Howard Dean, by Justin Elliot.
Search Results for: car t
Wikileaks cables shows Obama Administration role in lobbying EU to approve Oracle acquisition of MySQL and other Sun assets
Two cables recently disclosed by Wikileaks illustrate the degree to which the Obama Administration was monitoring the EU review of the Oracle acquisition of Sun, and leaning on the European Union to permit Oracle to acquire MySQL and other “open source” assets controlled by Sun.
Both cables were signed by Ambassador Christopher W. Murray, who served as Deputy Chief of Mission and Chargé d’Affaires at the United States Mission to the European Union, in Brussels, Belgium, from 2007 to 2010.
2,446 Wikileaks cables mentioning the search term “pharmaceutical”
The following are 2,446 cables from Wikileaks, that mention the search term: “pharmaceutical.” The search was conducted on August 29, 2011. This is an average of 23 cables per week, for the period. The cables are organized by dates.
- 05/07/01 Nigeria Embassy Abuja Oau Hiv/aids Summit In Abuja
- 10/23/01 Nigeria Embassy Abuja Nigeria: Trips And Access To Medicines
240 Wikileaks cables on pharmaceutical data exclusivity
August 29, 2011
From KEI staff review of Wikileaks cables (/wikileaks)
The following are the cables identified in an August 29, 2011 search of the wikileaks cables, from http://cablesearch.net, using the search terms data exclusivity and pharmaceutical. This search identified 240 cables. Some 40 countries are mentioned in the cables. More than half of the cables involve 5 countries: Turkey (76), Taiwan (21), El Salvador (11), Honduras (11) and Tunisia (10).
Misc notes on the new Wikileaks cables
These are some notes on some of the new Wikileaks cables. (Much more at /wikileaks)
May 18, 2009. Pfizer meets asks US embassy to intervene in Philippines debate over drug prices. Embassy agrees to tell Philippines government that “imposition of price controls . . . would be unacceptable..”
http://wikileaks.org/cable/2009/05/09MANILA1060.html
Subject: Health Department Patent Remedies to Cut Drug Prices
¶1. (SBU) Summary: The Philippine Department of Health is close to
Continue Reading
From Wikileaks, a US government cable on its involvement to shape Guatemala legislation on pharmaceutical IPR
August 28, 2011
From KEI staff review of Wikileaks cables (/wikileaks)
Among the many new cables released by Wikileaks is this gem, a detailed account of the U.S. government pressure on the Guatemala legislature to shape legislation on pharmaceutical test data IPR.
http://wikileaks.org/cable/2005/03/05GUATEMALA659.html
C O N F I D E N T I A L SECTION 01 OF 05 GUATEMALA 000659SIPDIS
E.O. 12958: DECL: 03/11/2010
TAGS: ETRD KIPR PGOV PREL GT
Continue Reading
Positive agenda on copyright, at the WIPO SCCR
As part of the American University hosted Global Congress on Intellectual Property and the public Interest, I participated in a panel on the positive agenda for intellectual property. These are notes from my talk.
Presentation by Manon Anne Ress, Knowledge Ecology International
August 26, 2011, at American University in Washington, DC
ADAP Financial Eligibility Criteria and ADAP Expenditures
AIDS Drug Assistance Programs (ADAP) serve low-income, underinsured or uninsured HIV-positive patients in the United States and its territories. General eligibility requirements may include residency, clinical eligibility based on specific CD4 counts, and income. Specific eligibility criteria for each ADAP is determined by each individual state. Continue Reading
ADAP waiting lists continue to grow; 9,217 individuals on waiting lists, 64% are African American or Hispanic
The number of patients sitting on AIDS Drug Assistance Programs (ADAP) wait lists, denied the life-saving treatment they need, have risen dramatically over the past two years. ADAPs are critical in providing HIV/AIDS treatment to low-income, uninsured, or underinsured patients within the United States and its territories. As noted in an earlier KEI blog, in January 2010, 361 individuals were on ADAP waitlists; that number grew to 7,873 across eleven states as of May 5, 2011 (a 2100% increase over less than sixteen months).
Approval, ownership, market structure, and placement on WHO EML for 100 new cancer NMEs on NCI alpha list
KEI research associate Paul Miano has written the following paper: Cancer: Approval, ownership, market structure, and placement on WHO Model Essential Medicines List, for 100 new molecular entities (NMEs) on the NCI alpha list of cancer drugs and vaccines. KEI Research Note 2011:1,
A full copy of the paper is available in PDF format here.
The following is from the introduction (sans footnotes, which are in the PDF version):